Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909799.0Aexternal-prioritypatent/GB9909799D0/en
Application filed by Amersham Health As, Gen Hospital CorpfiledCriticalAmersham Health As
Publication of AR021021A1publicationCriticalpatent/AR021021A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente caracteriza nuevos métodos de terapia de radiacion perfeccionada en base al descubrimiento del hecho que, usando combinaciones controladas de(i) composiciones radiodensas específicas, (ii) modos específicos de administracion de estascomp osiciones radiodensas y (iii) bandas de energía y fuentes deradiacion específicas, el efecto de radiacion sobre tumores y otros tejidos enfermos puede ser mejorado de manera efectiva y segura, para proporcionar unaterapia de radiacionsignificativame nte perfeccionada.The present characterizes new methods of improved radiation therapy based on the discovery of the fact that, using controlled combinations of (i) specific radiodense compositions, (ii) specific modes of administration of these radiodense compositions and (iii) energy bands and radiation sources specifically, the effect of radiation on tumors and other diseased tissues can be effectively and safely improved, to provide a significantly improved radiation therapy.
Use of cyclooxygenase-2- inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
A PHARMACEUTICAL COMPOSITION COMPRISING A DERIVATIVE OR ANALOGUE OF LEPTIN AS AN INHIBITOR OF THE PROLIFERATION OF TUMOR CELLS AND THE USE OF SUCH PHARMACEUTICAL COMPOSITION FOR THE MANUFACTURE OF MEDICINE FOR THE TREATMENT OF TUMORS